Evidence map›Paper›PMID 36129424›Full record

ArticlejLPHA : the official journal of the Louisiana Public Health Association2022

COVID-19 drive-through mass vaccination in Northwest Louisiana.

Deborah Gurgel Smith, John Anthony Vanchiere, Michelle Raley, Andrew David Yurochko, Mohammad Alfrad Nobel Bhuiyan, Kevin Sean Murnane, Rona Scott, Jeremy Kamil, Jill Rush-Kolodzey, Martha Whyte and 3 more

Open access · greenAbstract read
PubMed Full text at PMC
In one paragraph

Article in jLPHA : the official journal of the Louisiana Public Health Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Deborah Gurgel SmithDepartment of Public Health, Louisiana State University Health Shreveport, Shreveport, LA, USA.
John Anthony VanchiereDepartment of Pediatrics and Department of Infectious Diseases, Louisiana State University Health Shreveport, Shreveport, LA, U.S.A.
Michelle RaleyCenter of Excellence for Emerging Viral Threats, Louisiana State University Health Shreveport, Louisiana, U.S.A.
Andrew David YurochkoDepartment of Microbiology and Immunology, Louisiana State University Health Shreveport, Shreveport, LA, U.S.A.
Mohammad Alfrad Nobel BhuiyanDepartment of Medicine, Louisiana State University Health Shreveport, Louisiana, U.S.A.
Kevin Sean MurnaneDepartment of Pharmacology, Toxicology & Neuroscience, Department of Psychiatry, Louisiana State University Health Shreveport, Louisiana, U.S.A.
Rona ScottDepartment of Microbiology and Immunology, Louisiana State University Health Shreveport, Shreveport, LA, U.S.A.
Jeremy KamilDepartment of Microbiology and Immunology, Louisiana State University Health Shreveport, Shreveport, LA, U.S.A.
Jill Rush-KolodzeyDepartment of Public Health, Louisiana State University Health Shreveport, Shreveport, LA, USA.
Martha WhyteLouisiana Office of Public Health, Shreveport, Louisiana, U.S.A.
Kenneth DensmoreCenter of Excellence for Emerging Viral Threats, Louisiana State University Health Shreveport, Louisiana, U.S.A.
Maarten Van DiestCenter of Excellence for Emerging Viral Threats, Louisiana State University Health Shreveport, Louisiana, U.S.A.
Christopher KevilDepartment of Pathology and Translational Pathobiology, Louisiana State University Health Shreveport, Louisiana, U.S.A.
Louisiana State University in Shreveport · USLouisiana State University Health Sciences Center Shreveport · USLouisiana State Department of Health and Hospitals · US

Funding

The Administrative CoreP01AI127335 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI Patrizia Caposio · 2017 to 2026
$24.6M
Stress Exacerbates Myocardial Ischemic Injury by Blocking Estrogen's Antidoxidant Protection in the Female HeartP20GM121307 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI Vesna Tesic · 2018 to 2026
$23.6M
Project 4-Tracking cytomegalovirus-primed long-lived NK cells in salivary glandP20GM134974 · NIGMS · LOUISIANA STATE UNIV HSC SHREVEPORT · PI ANDREW D YUROCHKO · 2021 to 2026
$15.0M
Analysis of HCMV Infection of Monocytes and MacrophagesR01AI056077 · NIAID · LOUISIANA STATE UNIV HSC SHREVEPORT · PI YUROCHKO, ANDREW D · 2004 to 2020
$4.7M
CSE regulation of vascular remodelingR01HL149264 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI KEVIL, CHRISTOPHER G · 2020 to 2023
$1.7M
NHLBI NIH HHS R01 HL149264NIAID NIH HHS P01 AI127335NIAID NIH HHS R01 AI056077NIGMS NIH HHS P20 GM121307NIGMS NIH HHS P20 GM134974
6 · The paper itself

Abstract

Background: Vaccinating susceptible populations quickly and safely is vital during a pandemic. Mass vaccination programs using a drive-through method have been shown to reach large numbers of people efficiently during vaccine campaigns. Methods: We performed a quantitative, cross-sectional study analyzing data collected by the COVID-19 mass vaccination program conducted by Louisiana State University Health Shreveport (LSUSH). Results: Between December 2020 and September 2021, the vaccination program administered 90,655 COVID-19 vaccines. Among those who received at least the first dose of the vaccine, there were 21,700 men and 28,269 women; 22,820 were ≥60 years of age; 28,031 identified as Caucasian, 19,249 as African American, 47,916 as non-Hispanic, and most of them reported that they had not tested positive for COVID-19 before vaccination. Discussion: The LSUHS vaccination center served people from different regions within Louisiana as well as those from outside Louisiana. Vaccination is a crucial public health measure in the fight against the COVID-19 pandemic. Conclusions: Our study showed that the mass vaccination program conducted by LSUHS had a considerable positive impact on communities in Northwest Louisiana. This drive-through method is an effective strategy with which to reach a significant number of people during a pandemic.

Indexed as

CoronavirusCOVID-19Drive-throughMass vaccinationVaccines

Identifiers

PMID36129424
PMCPMC9484209
OpenAlexW4297891282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.